Cargando…
Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient
Drug-induced liver injury (DILI) has not been previously reported as a complication of treatment with everolimus. A 56-year-old Caucasian male liver transplant recipient developed DILI after receiving everolimus. Elevations in transaminase levels occurred within a week of starting everolimus and an...
Autores principales: | Patel, Serena, Mendler, Michel H., Valasek, Mark A., Tsunoda, Shirley M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076919/ https://www.ncbi.nlm.nih.gov/pubmed/30105113 http://dx.doi.org/10.1155/2018/7410508 |
Ejemplares similares
-
Everolimus associated interstitial pneumonitis in a liver transplant patient
por: Siddiqui, Atif S., et al.
Publicado: (2016) -
The role of everolimus in liver transplantation
por: Ganschow, Rainer, et al.
Publicado: (2014) -
Use of everolimus in liver transplantation
por: Yee, Mei-Ling, et al.
Publicado: (2017) -
Liver transplantation for azithromycin-induced severe liver injury
por: Park, Hyun Joon, et al.
Publicado: (2020) -
Drug‐induced liver injury by glatiramer acetate leading to liver transplant: A case report
por: Amirkhani, Nikan, et al.
Publicado: (2023)